Literature DB >> 15482468

Protease-activated receptor-2 (PAR-2) expression in human fibroblasts is regulated by growth factors and extracellular matrix.

Barry L Gruber1, Mary J Marchese, Frances Santiago-Schwarz, Carla A Martin, Jianhua Zhang, Richard R Kew.   

Abstract

Many cell types express a membrane receptor, activated by trypsin-like proteases, termed protease-activated receptor-2 (PAR-2). Previous studies describing PAR-2 expression on fibroblasts have been conflicting. In this report, we investigated in vitro PAR-2 expression on several fibroblast cell lines using flow cytometry, immunohistology, and immunoblots of cell lysates. Consistent PAR-2 expression was detected in cultured fibroblasts, although we observed heterogeneity of cellular expression among the cell lines. Some fibroblast lines expressed PAR-2 predominantly as an intracellular protein with differing cytoplasmic staining patterns, whereas other fibroblast lines displayed PAR-2 primarily as a cell surface receptor. Immunoblots of cell lysates with polyclonal anti-PAR-2 demonstrated a 44 kDa band, the predicted molecular weight for the PAR-2 core protein. Furthermore, we noted that expression of PAR-2 was subject to regulation. Fibroblasts grown within a collagen matrix downregulated receptor expression whereas increased PAR-2 expression was observed by the addition of fibroblast growth factors PDGF-BB and TGF-beta. This study may explain the previous inconsistencies in PAR-2 expression observed on tissue fibroblasts. Results indicate that the degree of fibroblast proliferation, attenuated by extracellular matrix and upregulated by growth factors, influences whether fibroblasts express PAR-2 and, thus, would be responsive to protease signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482468     DOI: 10.1111/j.0022-202X.2004.23445.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells.

Authors:  E Ritchie; M Saka; C Mackenzie; R Drummond; C Wheeler-Jones; T Kanke; R Plevin
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

2.  Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR(2) ) is involved in vascular function.

Authors:  M Bucci; V Vellecco; L Harrington; V Brancaleone; F Roviezzo; G Mattace Raso; A Ianaro; G Lungarella; R De Palma; R Meli; G Cirino
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

3.  Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea.

Authors:  Ji Young Kim; Yoon Jee Kim; Beom Jin Lim; Hyo Jung Sohn; Dongyun Shin; Sang Ho Oh
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

4.  Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease-Activated Receptor-2, in Human Corneal Epithelial Cells.

Authors:  Wannita Klinngam; Runzhong Fu; Srikanth R Janga; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  Int J Mol Sci       Date:  2018-11-09       Impact factor: 5.923

5.  Cigarette smoke extract enhances neutrophil elastase-induced IL-8 production via proteinase-activated receptor-2 upregulation in human bronchial epithelial cells.

Authors:  Kyoung-Hee Lee; Jinwoo Lee; Jiyeong Jeong; Jisu Woo; Chang-Hoon Lee; Chul-Gyu Yoo
Journal:  Exp Mol Med       Date:  2018-07-06       Impact factor: 8.718

6.  Electrospun tube reduces adhesion in rabbit Achilles tendon 12 weeks post-surgery without PAR-2 overexpression.

Authors:  Gabriella Meier Bürgisser; Olivera Evrova; Dorothea M Heuberger; Petra Wolint; Julia Rieber; Iris Miescher; Reto A Schüpbach; Pietro Giovanoli; Maurizio Calcagni; Johanna Buschmann
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

Review 7.  Protease-activated receptor-2: Role in asthma pathogenesis and utility as a biomarker of disease severity.

Authors:  Vivek Dipak Gandhi; Nami Shrestha Palikhe; Harissios Vliagoftis
Journal:  Front Med (Lausanne)       Date:  2022-07-29

8.  Identification of a small-molecule ligand of β-arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells.

Authors:  Kruthi Suvarna; Kaori Honda; Yasumitsu Kondoh; Hiroyuki Osada; Nobumoto Watanabe
Journal:  Cancer Med       Date:  2018-01-29       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.